Nanalysis Scientific Corp.
NSCI.V
TSX
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 13.28% | -7.58% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 13.28% | -7.58% | |||
| Cost of Revenue | 4.21% | -7.96% | |||
| Gross Profit | 36.24% | -6.60% | |||
| SG&A Expenses | -7.17% | -11.81% | |||
| Depreciation & Amortization | -3.63% | 1.53% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.54% | -7.26% | |||
| Operating Income | 132.16% | 3.84% | |||
| Income Before Tax | -344.05% | 17.72% | |||
| Income Tax Expenses | -977.27% | 150.00% | |||
| Earnings from Continuing Operations | -341.64% | 17.32% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -341.64% | 17.32% | |||
| EBIT | 132.16% | 3.84% | |||
| EBITDA | 176.25% | 5.57% | |||
| EPS Basic | -340.19% | 17.05% | |||
| Normalized Basic EPS | 60.00% | 10.96% | |||
| EPS Diluted | -220.41% | -0.68% | |||
| Normalized Diluted EPS | 60.00% | 10.96% | |||
| Average Basic Shares Outstanding | 0.03% | 0.06% | |||
| Average Diluted Shares Outstanding | 0.03% | 0.06% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||